ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Novartis Pharmaceuticals


Include trials that are no longer recruiting patients.

20 studies were found.
1.RecruitingBisphosphonate Treatment of Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
2.RecruitingThe Efficacy and Safety of Xolair in Children (6 - <12 years) with Moderate-Severe, Inadequately Controlled Allergic Asthma
Condition: Asthma
3.RecruitingEPO906 in Patients with Late Stage Non-Small-Cell Lung Cancer (NSCLC)
Conditions: Non-small cell lung cancer; NSCLC
4.RecruitingGleevec Trial in Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Condition: Chronic Myelogenous Leukemia
5.RecruitingNew bisphosphonate treatment for Paget's disease
Condition: Paget's Disease of Bone
6.RecruitingNew bisphosphonate treatment for Paget's disease
Condition: Paget's Disease of Bone
7.RecruitingNon-small Cell Lung Cancer Study US75 (Z-PACT)
Condition: Non Small Cell Lung Carcinoma
8.RecruitingOsteoarthritis Initiative (OAI): A Knee Health Study
Conditions: Osteoarthritis; Knee Osteoarthritis
9.RecruitingPediatric Hypothalamic Obesity
Condition: Obesity
10.RecruitingPKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes
11.RecruitingA Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
Condition: Prostate Cancer
12.RecruitingPTK 787 and Gleevec in Patients with AML, AMM, and CML-BP
Conditions: Acute Myelogenous Leukemia; Agnogenic Myeloid Metaplasia; Chronic Myelogenous Leukemia
13.RecruitingRAD001 in Patients with Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia in Blastic-Phase, Agnogenic Myeloid Metaplasia, Chronic Lymphocytic Leukemia, T-Cell Leukemia, or Mantle Cell Lymphoma
Conditions: Leukemia; Mantle Cell Lymphoma; Myelofibrosis
14.RecruitingRAD001 in Recurrent Endometrial Cancer
Condition: Endometrial Cancer
15.RecruitingStudy Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
Condition: Acromegaly
16.RecruitingStudy Evaluating SOM230 in Patients with Metastatic Carcinoid Tumors
Condition: Carcinoid Tumors
17.RecruitingA Study to Assess SOM230 in Patients with Pituitary Cushing’s Disease
Condition: Cushing's Syndrome
18.RecruitingTo evaluate the ability of an investigational drug to reduce the rate of all subsequent skeletal fractures after a hip fracture.
Conditions: Osteoporosis; Hip Fracture
19.RecruitingTreatment of Paget's Disease using Risedronate as a Comparator
Condition: Paget's Disease of Bone
20.RecruitingTreatment of von Hippel-Lindau (VHL)-Related Hemangioblastoma with PTK787/ZK 222584
Conditions: von Hippel-Lindau Disease; CNS hemangioblastoma; Retinal Hemangioblastoma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act